Related Experiment Video
Updated: Feb 25, 2026

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
Cisplatin Induced Acute Myocardial Infarction and Dyslipidemia
Lalith Prabhakar Hanchate1, Shimpa Rakesh Sharma2, Sadhana Madyalkar3
1Senior Resident, Department of General Medicine, Padmashri Dr D Y Patil Hospital and Research Institute, Kolhapur, Maharashtra, India.
Abstract:
Myocardial infarction commonly occurs due to rupture of atherosclerotic plaque in the coronary arteries and is manifested on coronary angiography. Myocardial infarction with angiographically normal coronary arteries can occur due to hypercoagulable state, coronary spasm, embolism, arteritis, congenital condition and drugs. Illicit drugs such as cocaine, amphetamines and marijuana are known to cause myocardial infarction. Of the many medications that are associated with cardiovascular toxicity, chemotherapeutic agents form a large group with both acute and delayed cardiotoxicity. We present a case of acute myocardial infarction in a patient with no organic coronary artery disease on the Bleomycin, Etoposide and Cisplatin (BEP) regimen for treatment of testicular seminoma. Patient developed symptoms of Acute Coronary Syndrome (ACS) after his third cycle of the regimen. This case highlights the need for prior careful cardiovascular evaluation, close monitoring and use of strategies to prevent cardiovascular morbidity in patients on cisplatin therapy.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies

